NBIX
USDNeurocrine Biosciences Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$141.970
Máximo
$143.870
Mínimo
$140.820
Volume
0.26M
Fundamentos da empresa
Capitalização de mercado
14.3B
Setor
Drug Manufacturers - Specialty & Generic
País
United States
Estatísticas de negociação
Volume médio
0.86M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Truist Securities Reiterates Buy on Neurocrine Biosciences, Raises Price Target to $172
Truist Securities analyst Danielle Brill reiterates Neurocrine Biosciences with a Buy and raises the price target from $165 to $172.
Canaccord Genuity Maintains Buy on Neurocrine Biosciences, Raises Price Target to $164
Canaccord Genuity analyst Sumant Kulkarni maintains Neurocrine Biosciences with a Buy and raises the price target from $160 to $164.
Stifel Maintains Buy on Neurocrine Biosciences, Raises Price Target to $183
Stifel analyst Paul Matteis maintains Neurocrine Biosciences with a Buy and raises the price target from $174 to $183.
RBC Capital Maintains Outperform on Neurocrine Biosciences, Raises Price Target to $160
RBC Capital analyst Brian Abrahams maintains Neurocrine Biosciences with a Outperform and raises the price target from $156 to $160.
Piper Sandler Maintains Overweight on Neurocrine Biosciences, Raises Price Target to $179
Piper Sandler analyst David Amsellem maintains Neurocrine Biosciences with a Overweight and raises the price target from $175 to $179.
Needham Maintains Buy on Neurocrine Biosciences, Raises Price Target to $184
Needham analyst Ami Fadia maintains Neurocrine Biosciences with a Buy and raises the price target from $170 to $184.
UBS Maintains Buy on Neurocrine Biosciences, Raises Price Target to $195
UBS analyst Ashwani Verma maintains Neurocrine Biosciences with a Buy and raises the price target from $188 to $195.
Ações relacionadas
HFRO
Highland Opportunities and Income Fund Common Shares of Beneficial Interest
GJS
Goldman Sachs Group Securities STRATS Trust for Goldman Sachs Group Securities Series 2006-2
AIT
Applied Industrial Technologies Inc.
ICCC
ImmuCell Corporation
AVA
Avista Corporation
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.